Anti-VSIG4 antibody

Cat.#: 142308

Special Price 145.0 USD

Availability:
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-VSIG4 antibody
  • Documents
  • Description
    Rabbit Polyclonal to Human VSIG4
  • Tested applications
    ELISA, IHC-P
  • Species reactivity
    Human VSIG4
  • Alternative names
    CRIg antibody; Z39IG antibody; CRIg antibody; Z39IG antibody; BC025105 antibody; A530061A11 antibody; A530061A11 antibody; BC025105 antibody; CRIg antibody; CRIg antibody; MGC36211 antibody; RP23-23B17.3 antibody; RP6-159A1.1 antibody; Vsig4 antibody; VSIG4 antibody; Z39IG antibody; Z39IG antibody
  • Immunogen
  • Isotype
    Rabbit IgG
  • Preparation
    Produced in rabbits immunized with purified, recombinant Human VSIG4 . VSIG4 specific IgG was purified by Human VSIG4 affinity chromatography.
  • Clonality
    Polyclonal
  • Formulation
    0.2 μm filtered solution in PBS
  • Storage instructions
    This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
    Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
  • Applications

    ELISA: 0.1-0.2 μg/ml

    This antibody can be used at 0.1-0.2 μg/ml with the appropriate secondary reagents to detect Human VSIG4.

    IHC-P: 0.1-2 μg/mL

  • Validations

    Human VSIG4 Immunohistochemistry(IHC) 14710

    Human VSIG4 Immunohistochemistry(IHC) 14710

    Human VSIG4 Immunohistochemistry(IHC) 14711

    Human VSIG4 Immunohistochemistry(IHC) 14711

  • Background
    VSIG4 (V-set and immunoglobulin domain containing 4), also known as complement receptor of the immunoglobulin superfamily (CRIg) and Z39Ig, is a type I  transmembrane glycoprotein. It is a B7 family-related protein and an Ig superfamily member. In contrast to the B7 family members which contain two IgG domains, VSIG4 contains one complete V-type I g domain and a truncated C-type I g domain. VSIG4 is exclusively expressed on tissue resident macrophages and binds to multimers of C3b and iC3b that are covalently attached to particle surfaces. No VSIG4 expression appears to be present in T and B cells. VSIG4 functions as a negative regulator of T cell activation, and may be involved in the maintenance of peripheral T cell tolerance, and is also identified as a potent suppressor of established inflammation. Mouse VSIG4 is synthesized as a 280 amino acid precursor that contains a signal sequence, an V-type I g domain (aa 36-115), one potential N-linked glycosylation site, and a single transmembrane domain. The V-type I g domain of mouse VSIG4 shares 86% and 80% aa sequence identity with the V-type I g domains of rat and human VSIG4, respectively.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"